221
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 115-123 | Received 23 Aug 2021, Accepted 15 Oct 2021, Published online: 11 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Juntao Yin, Yangyang Chen, Yang Li, Xingwang Zhang & Chaoyang Wang. (2022) Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis. Human Vaccines & Immunotherapeutics 18:6.
Read now
Danial Fazilat-Panah, Hamid Fallah Tafti, Yavar Rajabzadeh, Maedeh Alsadat Fatemi, Nahid Ahmadi, Davoud Jahansouz, Mohsen Tabasi, Seyed Alireza Javadinia, Maryam Joudi, Hadi Harati, Fahimeh Attarian & Farzad Taghizadeh-Hesary. (2022) Clinical Characteristics and Outcomes of COVID-19 in 1294 New Cancer Patients: Single-Center, Prospective Cohort Study from Iran. Cancer Investigation 40:6, pages 505-515.
Read now

Articles from other publishers (16)

Mario Caccese, Anna Maria Saieva, Valentina Guarneri, Sara Lonardi, Massimo Cacco, Vanna Chiarion Sileni, Michele Gottardi, Eleonora Mioranza, Francesca Bergamo, Antonella Brunello, Vittorina Zagonel & Patrizia Benini. (2022) Antigen rapid diagnostic test monitoring for SARS‐CoV ‐2 in asymptomatic and fully vaccinated cancer patients: Is it cost‐effective? . Cancer Medicine 12:7, pages 7795-7800.
Crossref
Kyoungmin Lee, In Hae Park, Sang Cheul Oh, Jae Hong Seo, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Ah‐reum Lim, Myung Han Hyun, Ju Won Kim, Jwa Hoon Kim, Yoon Ji Choi, Soohyeon Lee, Kyong Hwa Park, Yeul Hong Kim, Jung Yoon Choi, Jung Sun Kim, Se Ryeon Lee, Hwa Jung Sung & Eun Joo Kang. (2022) Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study. Cancer Medicine 12:5, pages 5558-5568.
Crossref
Yash B. Shah, Stephanie Kjelstrom, Diana Martinez, Adam Leitenberger, Donna‐Marie Manasseh, Melissa Bollmann‐Jenkins, Ann Partridge, Virginia Kaklamani, Rowen Chlebowski, Sharon Larson & Marisa Weiss. (2022) Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients . Cancer Medicine 12:3, pages 3577-3588.
Crossref
Fahimeh Safarnezhad Tameshkel, Shabnam Abedin Dargoush, Bahareh Amirkalali, Saeedeh Javadi, Ali Ghiaseddin, Yousef Alimohamadi, Ali Basi, Mahin Jamshidi Makiani, Farhad Zamani & Mohammad Hadi Karbalaie Niya. (2023) SARS-CoV-2 antibody response after BBIBP-CorV (Sinopharm) vaccination in cancer patients: A case-control study. Frontiers in Medicine 9.
Crossref
Mina Khosravifar, Sogol Koolaji, Negar Rezaei, Ali Ghanbari, Seyedeh Melika Hashemi, Erfan Ghasemi, Ali Bitaraf, Ozra Tabatabaei‐Malazy, Nazila Rezaei, Sahar Mohammadi Fateh, Arezou Dilmaghani‐Marand, Rosa Haghshenas, Ameneh Kazemi, Erfan Pakatchian, Farzad Kompani & Shirin Djalalinia. (2022) A year of experience with COVID ‐19 in patients with cancer: A nationwide study . Cancer Reports 6:1.
Crossref
Zhujun Cao, Chenxi Zhang, Shuang Zhao, Zike Sheng, Xiaogang Xiang, Ruokun Li, Zhuping Qian, Yinling Wang, Bin Chen, Ziqiang Li, Yuhan Liu, Baoyan An, Huijuan Zhou, Wei Cai, Hui Wang, Honglian Gui, Haiguang Xin & Qing Xie. (2022) COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status. Infectious Diseases of Poverty 11:1.
Crossref
Jingjing Lv, Hui Wu, Junjie Xu & Jiaye Liu. (2022) Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review. Infectious Diseases of Poverty 11:1.
Crossref
Zahraa Haleem Al-qaim, Hasanain Kamil Hasan Owadh, Sarah A. Ali, Alaa S. Hussein, Thamer Ramadhan Ameen, Ayshan Kolemen, Ghassan A. Washi & Abduladheem Turki Jalil. (2022) COVID-19 vaccination in patients with cancer: Opportunities and challenges. Frontiers in Oncology 12.
Crossref
Tong Li, Rui Song, Jingjie Wang, Jianbo Zhang, Hongxing Cai, Hongmei He, Wei Hu, Dajun Yu, Chuanhu Wang, Qingbo Pan, Mingli Peng, Hong Ren & Peng Zhu. (2022) Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer. International Journal of Infectious Diseases 122, pages 874-884.
Crossref
Haoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, Blake Nordblad, Nicolas Sayegh, Nishita Tripathi, Vinay Mathew Thomas, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal & Umang Swami. (2022) A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers. Heliyon 8:9, pages e10583.
Crossref
Mario Forrester, Luiza Breitenfeld, Miguel Castelo-Branco & Jorge Aperta. (2022) The Effects of the COVID-19 Pandemic in Oncology Patient Management. International Journal of Environmental Research and Public Health 19:15, pages 9041.
Crossref
Mahlagha Dehghan, Fatemeh Sadat Hoseini & Mohammad Ali Zakeri. (2022) Psychosomatic Symptoms in Terminally Ill Cancer Patients and Its Relation With Using Complementary and Alternative Medicines: A Cross-Sectional Study in Southeast Iran. Frontiers in Psychiatry 13.
Crossref
Yuling Han, Jiaxin Yang, Danshuang He, Yang Feng, Xiaoman Liu, Yu Min, Shenghao Fan, Guobing Yin & Daixing Hu. (2022) Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer. Frontiers in Immunology 13.
Crossref
Seyed Alireza Javadinia, Kimia Alizadeh, Mohammad-Shafi Mojadadi, Fateme Nikbakht, Farzaneh Dashti, Maryam Joudi, Hadi Harati, James S. Welsh, Seyed Amir Farahmand & Fahimeh Attarian. (2022) COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety. Frontiers in Endocrinology 13.
Crossref
Maryam Joudi, Maryam Moradi Binabaj, Pejman Porouhan, Babak PeyroShabany, Mohsen Tabasi, Danial Fazilat-Panah, Mahtab Khajeh, Arezoo Mehrabian, Mansoureh Dehghani, James S. Welsh, Batol Keykhosravi, Azam Akbari Yazdi, Mona Ariamanesh, Ahmad Ghasemi, Gordon Ferns & Seyed Alireza Javadinia. (2022) A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?. Frontiers in Endocrinology 13.
Crossref
Ke Zhou, Jean-Luc Raoul, Audrey Blanc-Lapierre, Valérie Seegers, Michèle Boisdron-Celle, Marianne Bourdon, Hakim Mahammedi, Aurélien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Martine M Bellanger & Frédéric Bigot. (2022) COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19). Clinical Medicine Insights: Oncology 16, pages 117955492210901.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.